ARTICLE SUMMARY:
FDA leads the way on early feasibility studies; ReWalk Robotics makes strides in exoskeleton reimbursement; updates on EU MDR, global harmonization, and China’s real-world data use. These stories and more in the current issue of Market Pathways, your source for global medical device regulatory, reimbursement, and policy intelligence and analysis.
